Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Be2b237e7645a37b03407b543cace1121> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Be2b237e7645a37b03407b543cace1121 NCIT_P378 "NCI" @default.
- Be2b237e7645a37b03407b543cace1121 type Axiom @default.
- Be2b237e7645a37b03407b543cace1121 annotatedProperty IAO_0000115 @default.
- Be2b237e7645a37b03407b543cace1121 annotatedSource NCIT_C2007 @default.
- Be2b237e7645a37b03407b543cace1121 annotatedTarget "A genetically-engineered, chimeric mouse-human, anti-CD30 monoclonal antibody with potential antineoplastic activity. Brentuximab specifically binds to the receptor CD-30, a member of the tumor necrosis factor receptor super-family, which may be overexpressed on the surfaces of Hodgkin lymphoma cells and anaplastic-large cell lymphoma cells. After binding to CD30, this agent interferes with the G1 phase of the cell cycle, thereby inducing growth arrest and apoptosis in susceptible tumor cell populations." @default.